Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

CEO

Harry Simeonidis

Employees

Country

United States

ISIN

US36151G7097

Listings

0 Comments

Share your thoughts

FAQ

What is Intelligent Bio Solutions stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Intelligent Bio Solutions stocks are traded under the ticker 12Q.MU.

When is the next Intelligent Bio Solutions earnings date?▼

Intelligent Bio Solutions is going to release the next earnings report on November 05, 2026.

What were Intelligent Bio Solutions earnings last quarter?▼

12Q.MU earnings for the last quarter are -1.35 EUR per share, whereas the estimation was -1.35 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.

How many employees does Intelligent Bio Solutions have?▼

As of August 27, 2026, the company has 60 employees.

In which sector is Intelligent Bio Solutions located?▼

Intelligent Bio Solutions operates in the Health & Wellness sector.

When did Intelligent Bio Solutions complete a stock split?▼

Intelligent Bio Solutions has not had any recent stock splits.

Where is Intelligent Bio Solutions headquartered?▼

Intelligent Bio Solutions is headquartered in NEW YORK, United States.